Correlation Between GM and Qualigen Therapeutics
Can any of the company-specific risk be diversified away by investing in both GM and Qualigen Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GM and Qualigen Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between General Motors and Qualigen Therapeutics, you can compare the effects of market volatilities on GM and Qualigen Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GM with a short position of Qualigen Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of GM and Qualigen Therapeutics.
Diversification Opportunities for GM and Qualigen Therapeutics
-0.81 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between GM and Qualigen is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding General Motors and Qualigen Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Qualigen Therapeutics and GM is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on General Motors are associated (or correlated) with Qualigen Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Qualigen Therapeutics has no effect on the direction of GM i.e., GM and Qualigen Therapeutics go up and down completely randomly.
Pair Corralation between GM and Qualigen Therapeutics
Allowing for the 90-day total investment horizon General Motors is expected to generate 0.28 times more return on investment than Qualigen Therapeutics. However, General Motors is 3.62 times less risky than Qualigen Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Qualigen Therapeutics is currently generating about -0.04 per unit of risk. If you would invest 3,749 in General Motors on August 29, 2024 and sell it today you would earn a total of 1,730 from holding General Motors or generate 46.15% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
General Motors vs. Qualigen Therapeutics
Performance |
| Timeline |
| General Motors |
| Qualigen Therapeutics |
GM and Qualigen Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GM and Qualigen Therapeutics
The main advantage of trading using opposite GM and Qualigen Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GM position performs unexpectedly, Qualigen Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qualigen Therapeutics will offset losses from the drop in Qualigen Therapeutics' long position.The idea behind General Motors and Qualigen Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Qualigen Therapeutics vs. ZyVersa Therapeutics | Qualigen Therapeutics vs. Immix Biopharma | Qualigen Therapeutics vs. Phio Pharmaceuticals Corp | Qualigen Therapeutics vs. 180 Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |